NCT03036514View on ClinicalTrials.gov

Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

August 1, 2019

Study Completion Date

September 1, 2019

Conditions
Pain, Postoperative
Interventions
DEVICE

Sublingual sufentanil tablet system

Usage of a new patient-controlled SSTS in the postoperative phase after laminectomy or spinal fusion.

DRUG

Patient-controlled intravenous analgesia

Usage of classically used patient-controlled intravenous mophine-based postoperative analgesia after laminectomy or spinal fusion.

Trial Locations (1)

2650

University hospital Antwerp, Edegem

All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

lead

University Hospital, Antwerp

OTHER

NCT03036514 - Sublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery. | Biotech Hunter | Biotech Hunter